Contacts: Marc Viscogliosi, Viscogliosi Bros, LLC (212) 583-9700 ext.
Nick Kilsby, EKK PR (203) 406-8800 ext. 21
VISCOGLIOSI BROS., LLC ANNOUNCES THE ADDITION OF GARY L. LOWERY, MD,
PhD. AS MEDICAL DIRECTOR
NEW YORK – May 26, 2004 – Viscogliosi Bros., LLC (VB), a
closely-held venture capital/private equity and merchant banking firm
focused on the musculoskeletal/orthopedics industry, is proud to announce
the addition of Gary L. Lowery, MD, PhD as Medical Director.
Dr. Lowery joined VB in April 2004 and will be an integral member of
the firm assisting VB continuing its global achievements as a leader
in the musculoskeletal/orthopedic sector.
Dr. Lowery is a world renowned spinal and orthopedic surgeon. Prior
to joining VB he was Chief of Spine Surgery and Director of Orthopedic
Research at the Phoenix Orthopedic Residency Program, as well as Medical
Director of Research Institute International, Inc.
Anthony G. Viscogliosi, Principal of VB, said, “Dr. Lowery is
one of the surgeons I have always held in the highest of regard since
I began my career analyzing the orthopedic industry more than 14 years
ago. As a scientist, surgeon, innovator, thought leader, and educator
/ trainer Dr. Lowery is one of the true visionaries in spine surgery
and musculoskeletal/orthopedics healthcare.”
As a scientist, Dr. Lowery has been intimately involved at every critical
level. He has been involved with preparing and executing 15 clinical
trials and 10 IDE clinical trails, six of which he was the principal
investigator. He has performed basic science in biomechanical testing
and experimental animal protocols for devices and biologics in rats,
sheep and baboons. Dr. Lowery has written more than 50 peer review articles
and book chapters, and has made more than 250 scientific presentations
throughout the world. Also, he has other experimental and clinical expertise:
the use of autologous growth factors (Interpore Cross, now Biomet, Inc.),
allograft products (Osteotech, Inc., Cortek, Inc.) for the stimulation
of bone fusion, and other biologics.
As an innovator, Dr. Lowery has directly and indirectly improved patient
care for many surgeons with his developments and refinements of surgical
techniques and implants. His accomplishments include: the Orion Anterior
Cervical Plate (Medtronic Sofamor Danek), the Acroflex Lumbar Total
Disc Prosthesis (Acromed, now Johnson & Johnson Depuy Spine), and
an integral role in the design of intervertebral titanium surgical mesh
(Depuy Motech, now Johnson & Johnson Depuy Spine). Dr. Lowery has
also been involved in the venture capital community assisting Endius,
Inc., Cortek, Inc., and SpineVision, Inc., to obtain funding.
Dr. Lowery has historically been a thought leader creating market trends
for the musculoskeletal/orthopedic and spine industries. Dr. Lowery
was a leader in the development and acceptance of total artificial discs,
working with Art Steffee, MD on the Acroflex Total Disc Replacement.
He is also a founding board member of the Spine Arthroplasty Society
(SAS), formed in 2000 to educate the spine surgeon community on non-fusion
spine surgery technologies.
Dr. Lowery has educated and trained more than 200 hundred surgeons throughout
the world, including 15 clinical and 6 research fellows. Dr. Lowery
has been instrumental in the design and teaching of endoscopic lumbar
surgery, both anterior approach (Acromed, now Johnson & Johnson
Depuy Spine) and posterior approach (Endius, Inc.). Dr. Lowery was instrumental
as a key surgeon and educator for several companies, most notably Danek
Medical, Inc. (now Medtronic Sofamor Danek), Depuy Motech (now Depuy
Spine), Synthes Spine, Endius, Inc., Osteotech, Inc., Cortek, Inc.,
and SpineVision, Inc.
VB strongly believes that Dr. Lowery adds an entirely new dimension
to the firm. VB will draw on Dr. Lowery’s multi-faceted and successful
career. “To have one of the world’s preeminent spinal surgeons
working with us daily, improves our speed and efficiency. We believe
this is one of our most valuable strategic decisions since our formation,”
said Marc R. Viscogliosi, Principal of VB. “This certainly creates
value within VB and will directly create value for our co-investors.”
About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony
G. Viscogliosi in New York City in 1999, VB was the first venture capital/private
equity and merchant banking firm dedicated to the musculoskeletal/orthopedics
sector of the health care industry. Today, VB is a leading independent
firm with a mission to create, build and finance companies founded on
innovations developed by surgeons and uniquely focused on "life
changing" musculoskeletal/orthopedic technologies. VB has worldwide
surgeon, industry and trade relationships and significant financial
expertise in the musculoskeletal/orthopedic sector.
As principals of VB, the Viscogliosi brothers have a combined total
of more than 35 years experience analyzing and investing in the musculoskeletal/orthopedics
sector. The have pioneered innovative financial, strategic and management
initiatives for companies in the sector, from start-up, seed and development
stage all the way to exit, while helping thousands of people lead better
lives through the orthopedic and spinal products marketed and sold by
the companies they have assisted in developing and financing.
> Back to Press Releases